Investment trust Biotech Growth (LON:BIOG) received another boost after Forte Biosciences (NASDAQ:FBRX) agreed a $2.2 billion takeover by Argenx (EBR:ARGX), a Belgian-Dutch pharmaceutical company. The Forte holding represents 3.03% of Biotech Growth’s net asset value (NAV). And the acquisition is the second takeover of one of the trust’s portfolio companies in a month as biotech’s M&A … Continue reading Biotech Growth Trust boosted by Forte Biosciences buyout